Related Experiment Videos
[Treatment for ovarian germ-cell tumors and the prognosis]
1Dept. of Obstetrics and Gynecology, Faculty of Medicine, University of Tokyo, Japan.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|May 3, 2000
Abstract:
This article reviews the major advances in therapy for malignant ovarian germ-cell tumors. Most of the important developments such as greatly improved survival and the preservation of reproductive potential in most young patients have occurred during the past two decades. We will also describe the major unresolved issues in this field.
Insights
This review covers recent advances in treating malignant ovarian germ-cell tumors, highlighting improved survival and fertility preservation for young patients over the last 20 years.
Area of Science:
- Gynecologic Oncology
- Reproductive Endocrinology
- Medical Oncology
Context:
- Malignant ovarian germ-cell tumors (GCTs) are rare but aggressive neoplasms.
- Significant therapeutic progress has been made in the last two decades.
Purpose:
- To review major advances in the therapy of malignant ovarian germ-cell tumors.
- To discuss current unresolved issues in the management of these rare tumors.
Summary:
- Therapeutic strategies for malignant ovarian GCTs have evolved, leading to dramatically improved patient survival.
- Reproductive potential is preserved in a majority of young patients treated for these tumors.
- Key developments include advances in chemotherapy regimens and surgical techniques.
Impact:
- Enhanced survival rates for patients with malignant ovarian germ-cell tumors.
- Improved quality of life through fertility preservation in young women.
- Identifies critical areas for future research and clinical trial development.